IFNL3 polymorphisms predict response to therapy in chronic hepatitis C genotype 2/3 infection.

Eslam, Mohammed; Leung, Reynold; Romero-Gomez, Manuel; Mangia, Alessandra; Irving, William L; Sheridan, David; Spengler, Ulrich; Mollison, Lindsay; Cheng, Wendy; Bugianesi, Elisabetta; McLeod, Duncan; Zaitoun, Abed M; Attino, Vito; Goeltz, Diane; Nattermann, Jacob; Douglas, Mark; Booth, David R; George, Jacob; Ahlenstiel, Golo.
J Hepatol; 61(2): 235-41, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24768758